Skip to main content

Table 2 FACS analysis

From: Administration of probiotics to healthy volunteers: effects on reactivity of intestinal mucosa and systemic leukocytes

 

Lp299

CURE21

Before

After

Before

After

Fibrinogen

2.54 ± 0.20

2.70 ± 0.20

3.11 ± 0.30

2.87 ± 0.22

CD3

1.76 ± 0.16

1.34 ± 0.14

1.51 ± 0.09

1.56 ± 0.15

CD4

1.08 ± 0.17

0.73 ± 0.06

0.95 ± 0.05

0.96 ± 0.11

CD8

0.56 ± 0.18

0.49 ± 0.12

0.51 ± 0.08

0.55 ± 0.09

CD19

0.20 ± 0.03

0.15 ± 0.03

0.23 ± 0.04

0.20 ± 0.03

CD16+56

0.31 ± 0.06

0.33 ± 0.05

0.26 ± 0.04

0.33 ± 0.04

HLR-DR

0.31 ± 0.06

0.35 ± 0.05

0.26 ± 0.04

0.33 ± 0.04

HLR-DR/CD3

0.07 ± 0.01

0.10 ± 0.03

0.08 ± 0.02

0.08 ± 0.02

CD25 of CD4

0.04 ± 0.01

0.05 ± 0.01

0.04 ± 0.00

0.05 ± 0.01

  1. Data presented as mean ± SEM. Fibrinogen: g/L; CD, HLR-DR: x109/L